Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Oslo, 16 February 2017 Record quarterly revenues of NOK 114.5 million, up 17% Driven by Asan and organic growth Fourth quarter adjusted EBITDA of NOK 28.8 million (margin 25.2%) ...
-
Oslo, 10 February 2017 Weifa ASA (OSE: WEIFA), Norway's leading consumer health company, will release its fourth quarter and full-year 2016 results on Thursday 16 February 2017. The results will...
-
Weifa has in-licensed a patented fixed-combination product line within pain management from AFT Pharmaceuticals ("AFT") in New Zealand. The agreement gives rights to commercialize the products in...
-
Weifa has signed a 3-year cooperation agreement with Midsona Finland Oy(Finland). The agreement covers Weifa's range of Asan products. Midsona will distribute and sell the products on an exclusive...